Patients with Bruck Syndrome typically present with symptoms from birth or early childhood. The hallmark features include:

• Bone Fragility: Similar to Osteogenesis Imperfecta, individuals have bones that break easily, often with minimal or no trauma.
• Joint Contractures: These are limitations in the range of motion of joints, often affecting the elbows, knees, and fingers.
• Other Features: Some patients may also exhibit scoliosis (curvature of the spine), blue sclerae (a bluish tint to the whites of the eyes), and hearing loss.

Diagnosing Bruck Syndrome involves a combination of clinical evaluation, family history, and genetic testing. The workup may include:

• Physical Examination: To assess bone fragility and joint contractures.
• Radiographic Imaging: X-rays can reveal bone abnormalities and fractures.
• Genetic Testing: Identifies mutations in specific genes associated with Bruck Syndrome, such as FKBP10 or PLOD2.

There is no cure for Bruck Syndrome, but treatment focuses on managing symptoms and improving quality of life:

• Orthopedic Care: To manage fractures and joint contractures, including surgical interventions if necessary.
• Physical Therapy: Helps maintain joint mobility and muscle strength.
• Bisphosphonates: Medications that may help increase bone density and reduce fracture risk.

The prognosis for individuals with Bruck Syndrome varies depending on the severity of symptoms. While the condition is lifelong, many patients can lead fulfilling lives with appropriate management. The risk of fractures and joint issues persists, requiring ongoing medical care and monitoring.

Bruck Syndrome is caused by genetic mutations that affect collagen production, a key component of connective tissue. Mutations in the FKBP10 or PLOD2 genes are most commonly associated with the disorder. These genes play a role in collagen cross-linking, which is crucial for bone strength and joint flexibility.

Bruck Syndrome is extremely rare, with only a few dozen cases reported in the medical literature. It affects both males and females equally and is inherited in an autosomal recessive pattern, meaning both parents must carry a copy of the mutated gene for a child to be affected.

The pathophysiology of Bruck Syndrome involves defects in collagen synthesis and processing. Collagen is a structural protein that provides strength and elasticity to bones and connective tissues. Mutations in the genes associated with Bruck Syndrome disrupt normal collagen formation, leading to fragile bones and joint contractures.

As a genetic disorder, Bruck Syndrome cannot be prevented. However, genetic counseling is recommended for families with a history of the condition. Prenatal testing and carrier screening can help assess the risk of passing the disorder to offspring.

Bruck Syndrome is a rare genetic disorder characterized by bone fragility and joint contractures. It is caused by mutations affecting collagen production, leading to symptoms similar to Osteogenesis Imperfecta. While there is no cure, treatment focuses on managing symptoms and improving quality of life through orthopedic care, physical therapy, and medications.

For patients and families affected by Bruck Syndrome, understanding the condition is crucial. It is important to work closely with a healthcare team to manage symptoms and prevent complications. Regular follow-ups with specialists, including orthopedic surgeons and physical therapists, can help maintain mobility and reduce fracture risk. Genetic counseling can provide valuable information for family planning and understanding the inheritance pattern of the disorder.